TEOSYAL® RHA2

Teosyal RHA 2 is a dermal filler gel manufactured in Switzerland by Teoxane Laboratories as part of the Teosyal RHA (Resilient Hyaluronic Acid) product range.

TEOSYAL RHA 2 Product Description

The gel is formulated to be durable enough to withstand repeated movements at mobile facial areas, providing correction to facial imperfections while maintaining a natural appearance. This product in particular is perfect for correcting moderate or medium facial lines and for increasing lip volume.

Teosyal RHA 2, a dermal filler gel manufactured in Switzerland by Teoxane Laboratories, is part of the Teosyal RHA (Resilient Hyaluronic Acid) product range. This gel is designed to withstand repeated movements in mobile facial areas, correcting facial imperfections while maintaining a natural appearance.

It is ideal for correcting moderate or medium facial lines and increasing lip volume. The filler contains an active substance of 23mg/mL of non-animal, cross-linked hyaluronic acid gel, combined with 0.3% lidocaine and a phosphate buffer solution with a pH of 7.3. The Teosyal product line includes:

• Teosyal Puresense Ultra Deep
• Teosyal Puresense Redensity 2
• Teosyal RHA 2
• Teosyal RHA3
• Teosyal Puresense Kiss
• Teosyal Puresense Ultimate
• Teosyal Puresense Redensity 1
• Teosyal Puresense Deep Lines

These fillers have specific indications that can target various facial areas, including the chin, lips, cheeks, under eyes, and signs of aging. Medical professionals should determine which Teosyal treatment can help patients with skin problems without compromising their health.

TEOSYAL RHA 2 Dermal Fillers Packaging

Medical professionals planning to buy Teosyal online should know what each box includes. These fillers’ gel formulation is supplied in 1mL syringes, and each Teosyal box contains:

• Two preloaded syringes with traceability labels
• 30G½” disposable needles
• An information pamphlet.

Teosyal RHA 2 is formulated using patented technology to produce resilient gel that offers correction of moderate wrinkles (e.g. nasolabial folds, glabellar lines), as well as fine lines on the face. Additionally, facial volume can be restored or augmented to a more desirable level with this soft tissue filler, giving the facial contour a more defined and polished look.

The Mechanism of Action of TEOSYAL Dermal Fillers

The manufacturer developed the Teosyal product line using Resilient Hyaluronic Acid Technology to create a durable, viscoelastic gel. This gel can withstand and support the skin even during dynamic facial movements, allowing wrinkles to be seamlessly filled in with natural-looking results. Additionally, lidocaine is incorporated into the filler to provide a comfortable, pain-free treatment experience for the patient.

Ageing can be divided into 2 categories: intrinsic and extrinsic ageing. Intrinsic ageing describes the unavoidable ageing process triggered by genetic signals. This process causes skin cells to suffer from a sluggish rate of production and decreased functionality. As a result, visible skin damage like pimple scars are not repaired as quickly as they used to be, leaving behind signs of ageing. This process can leave the skin looking dull and exhausted. Extrinsic ageing consists of the damage caused by external skin-damaging factors like UV rays, air pollution, unhealthy diet, and smoking. These factors introduce pesky free-radicals that exacerbate pre-existing skin health issues, making imperfections like wrinkles and lines deepen as time goes by.

Teosyal RHA 2 is created using Resilient Hyaluronic Acid Technology to form a sturdy and viscoelastic gel. The gel is able to withstand and support the skin even through very dynamic facial movements, allowing wrinkles to be filled in seamlessly with natural-looking results. Lidocaine has also been added into the filler in order to offer a comfortable, pain-free treatment session for the patient.

Although dermal filler injections are minimally invasive and can be completed quickly, they remain a medical procedure. Only legally certified, trained, and experienced physicians can administer Teosyal products. Each Teosyal treatment session must adhere to aseptic guidelines to minimize the risk of severe reactions, such as infections.

TEOSYAL RHA 2 Treatment Protocol

• During the initial consultation, review the patient’s medical history to identify any existing health issues, medications, and supplements that may contraindicate treatment with this product. A week before their planned session, advise patients to stop taking any blood-thinning agents, such as aspirin, vitamin E, or NSAIDs.
• Ensure the Teosyal formulation remains in its original packaging and is within its shelf life. Clean and sanitize the proposed injection site. Securely attach a needle to the prefilled syringe, ideally using the provided 30G needle. Remove the needle cap before use.
• Inject Teosyal RHA 2 into the problem area’s mid-dermis layer. Gently massage the treated area to promote better tissue integration of the gel. Dispose of any leftover gel and used needles.
• As part of aftercare, advise the patient to avoid wearing makeup for approximately 12 hours post-injection. They should also avoid exposure to extreme temperatures (e.g., sauna, hammam, intense cold) for one week after treatment.

Medical professionals must avoid overcorrecting with Teosyal fillers, which may result in an unnatural finish. Injecting too deeply into the subcutaneous layer may yield minimal skin improvements, while injecting too superficially may cause irregular effects. Refer to the Teosyal information pamphlet for additional usage instructions.

Though dermal filler injections are a minimally invasive process that can be completed quickly, it is still a medical procedure. Only legally certified, trained, and experienced physicians are permitted to administer soft tissue fillers. Every treatment session should also be completed following aseptic guidelines in order to decrease the risk of serious reactions like infections.

TEOSYAL RHA 2 Longevity of Results

The innovative Resilient Hyaluronic Acid Technology of Teosyal ensures that RHA 2 and its other fillers remain effective for up to 9 months or longer. These fillers consist of a biodegradable gel gradually absorbed by surrounding cells, necessitating patient return for injections once or twice a year to maintain optimal results. The longevity of effects of Teosyal dermal fillers can vary based on the patient’s age, health, and lifestyle.

Yes, Teosyal RHA 2 is a high-quality aesthetic filler derived from a tightly-regulated bacterial fermentation process, making it perfectly safe. This advanced manufacturing process also produces hyaluronic acid molecules that are extremely similar to the natural ones that are naturally present in the skin. The gel is also purified to be free from disease-transmitting pyrogens and is supplied for purchase in sterile packaging to ensure the utmost safety for patients. Patients can safely obtain filler injections with minimal risk of adverse reactions. However, certain circumstances can contraindicate patients from receiving this cosmetic filler treatment, including the following scenarios:

• Hypersensitive/allergic to any of the ingredients (e.g. hyaluronic acid, lidocaine);
• History of previous anaphylactic/allergic attacks;
• Presence of autoimmune/heart/liver disorders;
• Presence of dermal disorders (e.g. cold sore breakouts, acne, hives, wounds) on the treatment area.

Injecting the gel into blood vessels, superficial wrinkles, and eyelids is strictly prohibited. The use of this product in paediatric, pregnant, or lactating patients is also not permitted. Refer to the information pamphlet for more contraindications and warnings.

Proper Storage of TEOSYAL Products

Medical professionals and clinics should store Teosyal Puresense Utimate, Teosyal Puresense Redensity, Teosyal RHA Kiss, and all these dermal filler products in a clean, dry place between 2°C and 25°C, away from light, moisture, heat, and frost.

During the initial consultation, review the patient’s medical records and explain any potential side effects the patient may experience as a result of the treatment. These Teosyal common side effects can resolve within a few days to a week, but often do not require medical attention.

TEOSYAL RHA 2 Common Side Effects

• Redness
• Swelling
• Pain at the injection site

Rare Side Effects of TEOSYAL

Advise your patients to seek immediate medical help if symptoms last over a week. Educate them on proper recognition and reporting of unusual symptoms after their Teosyal treatments to manage them appropriately and prevent further complications.

• Allergic reactions
• Nodules
• Inflamed lumps
• Gel displacement
• Tissue death

For more possible reactions, refer to the information pamphlet.

Composition of TEOSYAL Fillers

This dermal filler contains 23mg/mL of non-animal, cross-linked hyaluronic acid gel combined with 0.3% lidocaine and a phosphate buffer solution with a pH of 7.3.

Teosyal RHA 2 offers aesthetic fillers of non-animal origin, formulated with advanced Resilient Hyaluronic Acid Technology. This ensures the gel is highly durable and robust enough for dynamic facial movements. Lidocaine is incorporated into the Teosyal formula to enhance patient comfort. The resulting gel is purified to be free from disease-transmitting pyrogens and is supplied in sterile packaging.

Where to Buy TEOSYAL Online

Licensed medical professionals can buy Teosyal online at Maylips to keep their products in stock for their practice. Order Teosyal online in the shop in bulk units at a discounted price. You can get free delivery with a minimum purchase of medical supplies or products. Each customer can ensure fast shipping of their purchased fillers or various products.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.